Strategic ConsiderationsFurther Development of the Rhine-Neckar Health and Life Science Region
9 October 2020
Leading representatives from science, research and healthcare present key points of a strategy paper
Strategic considerations on further developing the Rhine-Neckar Health and Life Science Region were the focus of a press conference which took place in Mannheim on 9 October 2020. Together, leading representatives of science, research and healthcare from Heidelberg and Mannheim presented the key points of a strategy paper to the Baden-Württemberg Science Ministry and the public at large.
Panelists:
Prof. Dr Ingo Autenrieth
Chairman of the Board and Chief Medical Director of Heidelberg University Hospital
Prof. Dr Michael Baumann
Chairman of the Management Board and Scientific Director of the German Cancer Research Center, Heidelberg
Freddy Bergmann
Commercial Manager of the University Hospital Mannheim
Prof. Dr Bernhard Eitel
Rector of Heidelberg University
Katrin Erk
Deputy Chairman and Administrative Director of Heidelberg University Hospital
Prof. Dr Sergij Goerdt
Dean of the Medical Faculty Mannheim of Heidelberg University
Prof. Dr Hans-Jürgen Hennes
Executive Board Chair and Medical Director of the University Hospital Mannheim
Dr Jan Korbel
Head of Data Science at the European Molecular Biolology Laboratory (EMBL) in Heidelberg and Co-Director of the Molecular Medicine Partnership Unit of the Medical Faculty Heidelberg and EMBL
Prof. Dr Hans-Georg Kräusslich
Dean of the Medical Faculty Heidelberg of Heidelberg University
Dr Peter Kurz
Lord Mayor of the City of Mannheim and Chair of the Supervisory Board of the University Hospital Mannheim
Prof. Dr Andreas Meyer-Lindenberg
Director of the Central Institute of Mental Health, Mannheim
Prof. Dr Joachim Spatz
Director of the Max Planck Institute for Medical Research, Heidelberg
The main considerations of the strategy paper can be accessed at:
Heidelberg Mannheim Health and Life Science Alliance (PDF)